Wilshire 10QSB 2002 Q3 Quarterly report (small business)

U.S. SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 10-QSB


(Mark One)
[X]		QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended August 31, 2002

[ ]		TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to

Commission File Number 0-20866

WILSHIRE TECHNOLOGIES, INC.

(Exact name of small business issuer as specified in its charter)


California (State or other jurisdiction of incorporation or organization)		33-0433823 (I.R.S. Employer Identification No.)

5861 Edison Place
Carlsbad, California 92008
(Address of principal executive offices)

(760) 929-7200
(Issuer’s telephone number)

Check whether the issuer (1) filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the past 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes [X] No [ ]

The number of shares outstanding of the registrant’s only class of Common Stock, no par value, were 20,964,423 on September 26, 2002.

Transitional Small Business Disclosure Format. Yes [ ] No [X]

TABLE OF CONTENTS


PART 1
	Item 1
		Condensed Consolidated Balance Sheets
		Condensed Consolidated Statements of Operations for the Three-Month Period Ended
		Condensed Consolidated Statements of Operations for the Nine-Month Period Ended
		Condensed Consolidated Statements of Cash Flows
	Item 2. Management’s Discussion and Analysis or Plan of Operation
	Item 3. Procedures and Controls
PART II — OTHER INFORMATION
	Item 1. Legal Proceedings:
	Item 2. Changes in Securities and Use of Proceeds:
	Item 3. Defaults Upon Senior Securities:
	Item 4. Submission of Matters to a Vote of Security Holders:
	Item 5. Other Information:
	Item 6. Exhibits and Reports on Form 8-K
SIGNATURES
EXHIBIT 10.221
EXHIBIT 10.222
EXHIBIT 10.223
EXHIBIT 10.224
EXHIBIT 99.1

WILSHIRE TECHNOLOGIES, INC.

INDEX TO FORM 10-QSB

PAGE

PART 1 - FINANCIAL INFORMATION (UNAUDITED)

Item 1.

Financial Statements:

Condensed Consolidated Balance Sheets as of August 31, 2002 (Unaudited) and November 30, 2001

Condensed Consolidated Unaudited Statements of Operations for the Three Months Ended August 31, 2002 and August 31, 2001

Condensed Consolidated Unaudited Statements of Operations for the Nine Months Ended August 31, 2002 and August 31, 2001

Condensed Consolidated Unaudited Statements of Cash Flows for the Nine Months Ended August 31, 2002 and August 31, 2001

Notes to Condensed Consolidated Unaudited Financial Statements

Item 2.

Management’s Discussion and Analysis or Plan of Operation

Item 3.

Procedures and Controls

PART II - OTHER INFORMATION

Item 1.

Legal Proceedings

Item 2.

Changes in Securities and Use of Proceeds

Item 3.

Defaults Upon Senior Securities

Item 4.

Submission of Matters to a Vote of Security Holders

Item 5.

Other Information

Item 6.

Exhibits and Reports on Form 8-K

Signatures

Wilshire Technologies, Inc.
Condensed Consolidated Balance Sheets
(See Note 2)

PART 1

Item 1.


		August 31,			November 30,
		2002			2001

		(Unaudited)			(Note 1)
Assets
Current assets:
	Cash	$	566,000		$	314,000
	Accounts receivable trade, less allowance for doubtful accounts of $375 at August 31, 2002 and November 30, 2001		54,000			46,000
	Inventories (Note 3)		122,000			38,000
	Other current assets		441,000			320,000

Total current assets			1,183,000			718,000
Property and equipment, net (Note 4)			5,481,000			2,644,000
Patents and trademarks, net			47,000			29,000
Receivable due from sale of division (Note 5)			—			687,000

		$	6,711,000		$	4,078,000

Liabilities and shareholders’ deficit
Current liabilities:
	Accounts payable	$	259,000		$	171,000
	Accrued expenses		619,000			390,000
	Interest payable-related party (Note 6)		6,705,000			5,164,000
	Line of credit- related party due on demand (Note 6)		25,769,000			18,704,000

Total current liabilities			33,352,000			24,429,000

Commitments and contingencies
Shareholders’ deficit (Note 6)
	Preferred stock, no par value, 2,000,000 shares authorized and none issued or outstanding		—			—
	Common stock, no par value, 100,000,000 shares authorized; 20,964,423 and 12,953,385 shares issued and outstanding at August 31, 2002 and November 30, 2001, respectively		27,204,000			25,912,000
	Common stock warrants and options		870,000			495,000
	Accumulated deficit		(54,715,000	)		(46,758,000	)

Total shareholders’ deficit			(26,641,000	)		(20,351,000	)

		$	6,711,000		$	4,078,000

See accompanying notes to financial statements.

Wilshire Technologies, Inc.
Condensed Consolidated Statements of Operations
(Unaudited)
(See Note 2)


		Three-Month Period Ended

		August 31,			August 31,
		2002			2001

Net sales		$	157,000		$	25,000
Cost of sales			1,731,000			824,000

Gross loss			(1,574,000	)		(799,000	)

Operating expenses:
	Marketing and selling		296,000			214,000
	General and administrative		244,000			315,000
	Research and development		—			10,000
	Loss due to impairment of fixed assets		600,000			—

Total operating expenses			1,140,000			539,000

Loss from operations			(2,714,000	)		(1,338,000	)
Other income, net			137,000			81,000
Interest expense, net			(578,000	)		(475,000	)

Loss before provision for income taxes			(3,155,000	)		(1,732,000	)
Provision for income taxes			—			—

Net loss		$	(3,155,000	)	$	(1,732,000	)

Weighted average shares outstanding			20,964,000			12,953,000

Basic and diluted loss per share		$	(0.15	)	$	(0.13	)

See accompanying notes to financial statements.

Wilshire Technologies, Inc.
Condensed Consolidated Statements of Operations
(Unaudited)
(See Note 2)


		Nine-Month Period Ended

		August 31,			August 31,
		2002			2001

Net sales		$	384,000		$	155,000
Cost of sales			4,068,000			1,991,000

Gross loss			(3,684,000	)		(1,836,000	)

Operating expenses:
	Marketing and selling		757,000			504,000
	General and administrative		1,247,000			1,216,000
	Research and development		2,000			34,000
	Loss due to impairment of fixed assets		600,000			—

Total operating expenses			2,606,000			1,754,000

Loss from operations			(6,290,000	)		(3,590,000	)
Other income, net			262,000			280,000
Interest expense, net			(1,928,000	)		(1,384,000	)

Loss before provision for income taxes			(7,956,000	)		(4,694,000	)
Provision for income taxes			1,000			1,000

Net loss		$	(7,957,000	)	$	(4,695,000	)

Weighted average shares outstanding			19,879,000			12,953,000

Basic and diluted loss per share		$	(0.40	)	$	(0.36	)

See accompanying notes to financial statements.

Wilshire Technologies, Inc.
Condensed Consolidated Statements of Cash Flows
(Unaudited)
(See Note 2)


				Nine-Month Period Ended

				August 31,			August 31,
				2002			2001

Operating activities
Net loss				$	(7,957,000	)	$	(4,695,000	)
Adjustments to reconcile net loss to net cash used in operating activities:
		Depreciation and amortization			568,000			486,000
		Options Issued to Majority Shareholder			375,000			—
		Loss from Write Off of Assets			142,000			—
		Loss due to Impairment of Fixed Assets			600,000			—
		Net change in operating assets and liabilities
			Increase in accounts receivable		(8,000	)		(18,000	)
			Increase in inventories		(84,000	)		(100,000	)
			Increase in other current assets		(121,000	)		(65,000	)
			Increase in accounts payable and accrued expenses		317,000			234,000
			Increase in interest payable		1,554,000			1,385,000

Net cash used in operating activities					(4,614,000	)		(2,773,000	)

Investing activities
	Purchases of equipment				(4,145,000	)		(280,000	)
	Proceeds from note receivable				687,000			—
	Increase in other assets				(20,000	)		—

Net cash used in investing activities					(3,478,000	)		(280,000	)

Financing activities
	Proceeds from line of credit				8,344,000			3,165,000

Net cash provided by financing activities					8,344,000			3,165,000

Net increase in cash					252,000			112,000
Cash – beginning of period					314,000			413,000

Cash – end of period				$	566,000		$	525,000

See accompanying notes to financial statements.

NOTE 1. ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Organization

Wilshire Technologies, Inc. (the “Company”) operates in one business segment, which is to develop, manufacture and market engineered polymer products for industrial cleanroom use. The Company has historically developed, manufactured and marketed engineered polymer products for industrial cleanroom use. In 1996, the Company divested its Medical Products and Transdermal Products divisions and focused primarily on products used in industrial cleanrooms, such as gloves and contamination control products. From 1996 through 2000, substantially all of the Company’s reported historic revenues have been related to sales of its contamination control products. On May 19, 2000, the Company completed the sale of certain assets and selected liabilities of the Company’s Wilshire Contamination Control division (the “division”) to Foamex Asia Co. LTD. (see Note 5). During the third quarter of fiscal 2000, sales of the Company’s polyurethane glove ceased and the Company focused upon securing a strategic partner for the new product development. Effective September 18, 2000, the Company signed a Product Development, Purchase and License Agreement (the “Agreement”) with the Lycra® division of E. I. DuPont de Nemours and Company (“DuPont”). Under the Agreement, DuPont developed and began to supply a new proprietary polyurethane material which is used by Wilshire to manufacture and sell a disposable polyurethane glove for industrial cleanroom applications. The Company, based in Carlsbad, California manufactures its products at the Tijuana, Mexico facility of its wholly owned subsidiary, Wilshire International de Mexico S.A. de C.V.

Basis of Presentation

The Company has incurred substantial losses since its inception in 1990, and has relied on working capital provided by Trilon Dominion Partners, LLC (“Trilon Dominion"-previously Dominion Capital, Inc.) in the form of both debt and equity to fund its operations. Management believes that Trilon Dominion will continue to support the Company as necessary through the end of fiscal year 2002.

The accompanying condensed consolidated unaudited financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information and with the instructions to Form 10-QSB for quarterly reports under Section 13 or 15(d) of the Securities Exchange Act of 1934. Accordingly, they do not include all of the information and footnotes required by accounting principles generally accepted in the United States of America for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the three and nine months ended August 31, 2002 are not necessarily indicative of the results that may be expected for the fiscal year ending November 30, 2002. For further information, refer to the consolidated financial statements and footnotes thereto included in the Company’s annual report on Form 10-KSB for the fiscal year ended November 30, 2001.

The consolidated financial statements include the accounts of the Company and its wholly owned subsidiary. Significant intercompany amounts and transactions have been eliminated.

NOTE 2. GOING CONCERN

The Company’s consolidated financial statements included elsewhere herein have been prepared assuming that the Company will continue as a going concern. The Company has a working capital deficiency of $32,169,000 and a shareholders’ deficit of $26,641,000 as of August 31, 2002, has suffered substantial recurring losses from operations and is economically dependent on its majority shareholder to finance operations. These matters, among others, raise substantial doubt about the Company’s ability to continue as a going concern. Continuation of the Company is dependent on the Company’s ability to negotiate additional arrangements with its majority shareholder, raise additional capital and to achieve profitability. The consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty. Although management has been successful in obtaining working capital from its majority shareholder to fund operations to date, there can be no assurance that the Company will be able to raise additional capital in the future.

financial support to the Company through the end of the calendar year 2002 to the extent of such budgeted cash flow requirements. However given that no written commitment exists, the Company is exposed to the substantial risk that it will not receive the funds from Trilon Dominion to fund present and future working capital needs. In the event that such funds are not received it is unlikely that the Company will be successful in raising capital from other sources. If adequate funds are not available to finance current operations, the Company will be unable to execute its business development efforts and may be unable to continue as a going concern.

The Company’s continuation as a going concern is dependent upon its ability to (a) generate sufficient cash flow to fund working capital and investment activities, (b) to obtain additional outside financing, and (c) ultimately obtain and sustain profitability. Management’s recent actions in regard to these matters are as follows:

1) During fiscal 2000, the Company sold selected assets and liabilities totaling $945,000 related to the Company’s Wilshire Contamination Control to Foamex Asia Co. LTD. (the “Buyer”), an affiliate of Foamex International (FMX: NASDAQ) for a potential sales price up to $2,500,000. (See Note 5). Payments of the sale price are due from the Buyer on a quarterly basis based on a fixed percentage of sales by the Buyer of certain products. Foamex International is an international developer, manufacturer and supplier of high-quality foam, including key materials utilized in contamination control environments. Foamex Asia Co. Ltd., located in Singapore and in Thailand, is currently a major supplier of specialty foam products to the Asian market.

As part of the sale agreement, Foamex Asia Co. Ltd. agreed to invest $1,000,000 of capital in equipment and machinery which, the Company believes, will lead to lower manufacturing costs of the Buyer over the term of the agreement. The Company further believes the transaction was in its best interests as the likelihood of increased sales due to the lower manufacturing costs may provide not only a return of the initial investment of $945,000, but additional payments from the Buyer up to a total of $2,500,000.

In accordance with the terms of the sale agreement, a payment in the amount of $258,000 was received from Foamex Asia Co. Ltd., on November 29, 2001 and applied against the receivable. During the first nine months of 2002, the Company received three additional payments totaling approximately $780,000 from Foamex Asia Co. Ltd., of which $687,000 was applied to the remaining principal balance — now paid in full — and $93,000 recognized as other income in the third quarter ended August 31, 2002.

2) In addition to the sale of assets to Foamex Asia Co. Ltd., the Company entered into an agreement with Foamex to provide, for due consideration, certain labor, facilities, services, personnel and other items with respect to Foamex’s ongoing operation of the Division’s business. The agreement, which commenced on May 19, 2000, has been amended to extend through December 31, 2002 and will provide additional funds to offset operating expenses of approximately $550,000 for fiscal year 2002.

3) In September 2000, the Company signed a Product Development, Purchase and License Agreement (the “Agreement”) with the LYCRA® division of E. I. DuPont de Nemours and Company (“DuPont”). Under the Agreement, DuPont developed and began to supply a new proprietary polyurethane material, which is used by Wilshire to manufacture and sell a disposable polyurethane glove for industrial and non-industrial cleanroom applications.

The Agreement grants the Company an exclusive two-year license to purchase the “Material” for the manufacture of its glove for sale into the cleanroom, non-medical glove markets of North America, Asia (ex-Japan) and Japan. The Agreement allows for up to three annual extensions of the exclusivity period for the purchasing rights and for the selling rights into North America and Asia (ex-Japan) upon the Company meeting certain performance criteria. In order to maintain the exclusivity of the purchasing and selling rights beyond the initial two-year period, the Company is required to meet annual revenue thresholds of $6.9M, $16.3M and $26.5M for the 12-month periods ending June 30, 2003, 2004 and 2005, respectively. If the Company does not meet the stated minimum revenue requirement, the Company can obtain annual non-exclusive rights in these markets upon achievement of lesser annual thresholds of $3.45M, $8.15M and $13.25M for the 12-month periods ending June 30, 2003, 2004 and 2005, respectively. Given that Company’s sales for the first nine months of fiscal 2002 totaled $384,000, it is unlikely that the Company will meet the minimum revenue requirements for the 12 month period ending June 30, 2003. Although the Company is in discussions with DuPont regarding the modification of the revenue threshold requirements, the License Agreement has not been modified nor are there any assurances from DuPont that it will be. Therefore, there can be no assurance that the DuPont will extend the rights to use DuPont’s Material, on an exclusive or non-exclusive basis, for periods beyond the initial two-year period.

Under the Agreement, the Company is required to purchase all its polyurethane requirements from DuPont through the end of 2005, if the extensions are exercised. In conjunction with the Agreement, the Company also entered into a Trademark License Agreement with Dupont that allows the Company to market the new polyurethane glove under the LYCRA® trademark.

As partial consideration, in fiscal year 2000, the Company granted a stock option to DuPont to purchase up to 2,000,000 shares of its common stock at an exercise price of $.50 a share. This option was cancelled effective December 17, 2001 at which time the Company granted DuPont a different option with an exercise price of $1 million.

Upon exercise of the new option, DuPont would receive 10% of the proceeds (as defined in the option) from (i) any voluntary or involuntary liquidation, dissolution or winding up of the Company, (ii) the sale of substantially all of the Company’s assets by the Company, or (iii) the acquisition of the Company by another entity, not affiliated with Trilon Dominion, by means of a merger or other form of corporate reorganization in which the outstanding shares of the Company are exchanged for securities or other consideration issued by or on behalf of the acquiring corporation (collectively a “Liquidation”).

In the event of Liquidation before December 31, 2004, the option becomes exercisable on the day the Liquidation occurs. If there has been no Liquidation before December 31, 2004, the option becomes exercisable on December 30, 2004 and, if not exercised, expires at the close of business on that day. The Company, may in its sole discretion, extend the December 31, 2004 date on at least 15 calendar days prior written notice to DuPont.

The Company began production of the new gloves in the third quarter of 2001 and believes that the new, improved DuraCLEAN® gloves using LYCRA® eglantine fiber will offer the market a glove with improved cleanliness, durability and comfort. The glove will also have excellent ESD properties. The glove has the distinct advantage of being able to be used as a one time disposable product or, because of its durability, can be relaundered and used multiple times. The relaunderability benefit is a significant factor as it allows for a reduction in the cost of the glove and a large reduction in the waste stream of the customer, which is a growing concern in the market.

Although the new gloves will be premium priced, management believes they will be cost effective for users because the enhanced cleanliness will reduce contamination and increase yield. Also, because of excellent abrasion resistance they can be worn longer and changed less frequently than less expensive gloves.

Because of the inherent cleanliness and the absence of chemical accelerators, the new DuraCLEAN® with LYCRA® glove has expanded applications outside traditional cleanroom markets. Some of the fastest growing market-segments for Wilshire Technologies Inc. are medical device manufacturing, telecommunications, biotechnology and highly sensitive laboratories. The ability to re-launder and re-use the DuraCLEAN® glove has appeal in waste sensitive markets in Japan.

The Glove will be marketed under the trademark DuraCLEAN® with LYCRA®. DuPont will be active with the Company in the marketing of the product. The Company will distribute the product through a variety of channels both in the US and overseas.

The Company believes that with the potential of a return of $2,500,000 — of which $1,038,000 has been received by the Company as of August 31, 2002 — on the sale of its contamination control division to Foamex Asia Co., Ltd., with the cost-sharing agreements in place to lower operating costs, with the sales of its new glove, and with continued funding from Trilon Dominion, the Company will position itself to begin generating sufficient cash flow to fund working capital and investment activities by the end of 2003. If the Company does attain its sales goals, it believes that it will be able to raise additional capital, as needed in the future. There can be no assurances, however, that the Company will be successful in any of the above mentioned actions or plans on a timely basis, or at all.

NOTE 3. FINANCIAL STATEMENT INFORMATION

Inventories consist of the following:


	August 31,			November 30,
	2002			2001

Raw materials	$	95,000		$	40,000
Work in process		3,000			—
Finished goods		56,000			30,000
Inventory reserves		(32,000	)		(32,000	)

	$	122,000		$	38,000

NOTE 4. LONG TERM ASSETS

Property and equipment consist of the following:


	August 31,			November 30,
	2002			2001

Machinery and Equipment	$	3,654,000		$	4,303,000
Furniture and Office Equipment		566,000			512,000
Leasehold improvements		634,000			222,000
Construction in progress		3,260,000			329,000

	$	8,114,000		$	5,366,000
Less accumulated depreciation and amortization		(2,633,000	)		(2,722,000	)

	$	5,481,000		$	2,644,000

The Company has adopted the provisions of SFAS 121, “Accounting for the Impairment of Long-Lived Assets and for Long-Lived Assets to be Disposed Of ”. This statement requires that long-lived assets and certain identifiable intangibles be reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by comparison of the carrying amount of an asset to future net cash flows expected to be generated by the asset. If such assets are considered impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the fair value of the assets. Assets to be disposed of are reported at the lower of the carrying amount or fair value less costs to sell.

During the third quarter of fiscal 2002, the Company continued extensive capital expansion programs to increase capacity levels and production efficiencies of the glove plant. As part of the expansion, the Company wrote off assets deemed no longer recoverable with a net book value of $97,000. Additionally, the Company identified certain assets totaling $600,000 associated with the original glove dipping line to be replaced early in fiscal 2003. In accordance with the Company’s accounting policies, the depreciable life of the asset would be adjusted to fully depreciate the asset by early 2003. However, due to the uncertainty as to the Company’s ability to recover its investment in its long-term assets through the generation of future net cash flows through 2003, the Company recognized a loss due to impairment of such assets totaling $600,000 in the third quarter ended August 31, 2002.

The Company has evaluated the recoverability of the assets associated with its existing glove plant by measuring the carrying cost of those assets — after write downs — against the estimated undiscounted future cash flows associated with those assets. The future cash flows calculated by the analysis appeared sufficient to recover the value of the assets and thus no write down of the asset was recorded.

However, the Company acknowledges that the losses associated with the development of a polyurethane glove extended beyond the initial plan due primarily to the extension of the time related to the strategic decision to find another source of polymer (a new proprietary polyurethane material developed and supplied by DuPont). The Company further acknowledges that the recoverability of its long term assets depends upon the Company increasing its manufacturing capacity of its glove dipping plant and also substantially increasing sales of its glove beyond historic sales recorded for the previous twelve months.

During the third quarter of fiscal 2002, the Company continued extensive capital expansion programs to increase capacity levels and production efficiencies of the glove plant. The Company entered into a contract with a glove line manufacturer to construct two additional glove lines, with installation of the first of the two lines to take place in the

last fiscal quarter of 2002. Due to the length of time needed to expand manufacturing capacity, (9 to 12 months per glove line), the Company anticipates that full capacity and manufacturing efficiencies associated with the new lines will not be attained until mid 2003.

However, if the Company continues to experience production delays and does not achieve higher production output and corresponding sales growth by the end of fiscal 2002, the Company may have to substantially reduce its assumptions regarding the future cash flow associated with certain long term assets (i.e. the initial glove line) and recognize an additional write down of assets at that time. As a result, given the Company’s unprofitable past financial performance and the unpredictability of its future performance, there is substantial uncertainty as to the Company’s ability to recover its investment in its long-term assets through the generation of future net cash flows. In light of such uncertainty, the Company may seek an independent third party valuation of its long term assets by the end of fiscal 2002 to support the fair value of such assets, or an impairment charge, if any, that is to be recognized.

NOTE 5. SALE OF DIVISION

On May 19, 2000, the Company completed the sale of certain assets and selected liabilities of the Company’s Wilshire Contamination Control division (the “division”) to Foamex Asia Co. LTD. (the “Buyer”), an affiliate of Foamex International (FMX:NASDAQ) for a potential sales price up to $2,500,000. Substantially all of the historic revenues reported by the Company related to this division.

Payments are due from the Buyer on a quarterly basis based on a fixed percentage of sales by the Buyer of certain products, as defined in the asset purchase agreement, subject to certain cash flow provisions.

As no proceeds were due to the Company on the date of closing, the Company recorded a receivable, which equated to the net book value of the net assets sold. Such receivable totaled $945,000. All payments of the sales price were applied against the receivable, under the cost recovery method, with no recognition of gain until the receivable was paid in full. On November 29, 2001, the Company received a payment of $258,000 from Foamex Asia Co. Ltd., in compliance with the terms of the Agreement, which was applied against the receivable. During the first nine months of 2002, the Company received three additional payments totaling approximately $780,000 from Foamex Asia Co. Ltd., of which $687,000 was applied to the remaining principal balance — now paid in full — and $93,000 recognized as other income in the third quarter ended August 31, 2002.

In addition to the sale of assets, the Buyer and Seller entered into an agreement (the “Ongoing Service Agreement”) where the Company agreed to provide Foamex, for due consideration, certain labor, facilities, services, personnel and other items with respect to Foamex’s ongoing operation of the Division’s business. The agreement commenced on May 19, 2000 and has been subsequently amended to continue until December 31, 2002. The Company anticipates receiving approximately $550,000 from the agreement during fiscal year 2002, of which $345,000 has been received through August 31, 2002.

NOTE 6. LINE OF CREDIT

On March 31, 1998, the Company and Trilon Dominion Partners, L.L.C. (“Trilon”) completed an Amended and Restated Credit Agreement and Revolving Line of Credit (the “Amended Agreement”), secured by the Company’s assets.

The Agreement has been extended through a number of amendments to January 31, 2003. Through fiscal 1999, the Company issued $11,935,000 of demand notes bearing interest at rates of 11.5% and prime plus 3%.

In fiscal 2000, the Company issued demand notes totaling $2,813,000 under the line of credit agreement. The notes issued in fiscal 2000 bear interest at a rate of prime plus 3%.

For the first nine months of fiscal 2001, the Company issued demand notes totaling $3,165,000 at a rate of prime plus 3%. All of the notes are due on demand. On October 5, 2001, November 5, 2001 and December 7, 2001, the Company issued additional demand notes totaling $1,279,000 at a prime rate of prime plus 3%, plus additional interest totaling $12,000 on such notes.

Stock at $0.14 per share, exercisable at any time before 2003; (ii) an option, to be issued upon approval of an increase in the Company’s authorized stock, to purchase an additional 1,600,000 shares of Common Stock, which may also be purchased at $0.14 per share at any time before 2003; and (iii) an additional option to purchase from the Company at $0.14 per share that number of shares of Common Stock necessary to increase Trilon’s beneficial ownership of the Company’s Common Stock to 90% of the shares outstanding after exercise of all options granted in the Agreement and after the deemed exercise of all other then outstanding options and warrants. The options granted to Trilon under the Agreement may be exercised for cash or, at Trilon’s election, by canceling outstanding indebtedness of the Company to Trilon in an amount equal to the exercise price.

The Agreement contains certain covenants regarding corporation events which restrict the Company, without the prior written consent of Trilon, from (a) issuing any shares of its Preferred Stock, (b) issuing any shares of its Common Stock except pursuant to warrants or options outstanding on the date of the Agreement, (c) paying any dividend payable in stock (of any class or classes) or in any obligations or stock convertible into or exchangeable for shares of Common Stock, upon its Common Stock or make any distribution (other than ordinary cash dividends) to holders of its Common Stock, (d) granting to holders of its Common Stock generally any rights or options, (e) effecting any capital reorganization or reclassification of capital stock of the Company, (f) consolidating with, or merging into, any other corporation or to transfer its property as an entirety or substantially as an entirety, or (g) effecting the liquidation, dissolution or winding up of the Company. These covenants remain in effect until the option and additional option have been exercised or expired. As of August 31, 2002, the Company is in compliance with such covenants. In connection with any consent of Trilon to the foregoing, Trilon may require adjustments to the exercise price in order to protect its purchase rights with respect to the option. Trilon may exercise the option at any time before 2003. The fair value of the option granted was estimated to be $375,000, which was recorded as interest expense in the first quarter of 2002.

The Company issued two additional demand notes during the first quarter of fiscal 2002. On January 9, 2002, and February 13, 2002, demand notes totaling $2,155,000 were issued at a rate of prime plus 3% (7.75% at August 31, 2002). During the second quarter of fiscal 2002, the Company issued three additional demand notes. On March 11, 2002, April 22, 2002 and May 9, 2002, demand notes totaling $2,528,000 were issued at a rate of prime plus 3% (7.75% at August 31, 2002). In the third quarter of fiscal 2002, the Company issued four additional demand notes. On June 7, 2002, July 2, 2002, August 6, 2002 and August 19, 2002, demand notes totaling $3,173,000 were issued at a rate of prime plus 3% (7.75% at August 31,2002).

NOTE 7. COMMITMENTS AND CONTINGENCIES

Breast Implant Litigation

During the first nine months of 2002, there have been no significant developments in the Breast Implant Litigation. For information regarding legal proceedings, refer to the information contained in the Company’s Annual Report on Form 10-KSB for the fiscal year ended November 30, 2001, under Note 7 to the consolidated financial statements included therein.

Item 2. Management’s Discussion and Analysis or Plan of Operation

With the exception of discussions regarding historical information, “Management’s Discussion and Analysis or Plan of Operation” contains forward looking statements. Such statements are based on current expectations subject to uncertainties and other factors which may involve known and unknown risks that could cause actual results of operations to differ materially from those projected or implied. Further, certain forward-looking statements are based upon assumptions about future events which may not prove to be accurate.

Risks and uncertainties inherent in forward looking statements include, but are not limited to, the Company’s future cash flows and ability to obtain sufficient financing, timing and volume of sales orders, level of gross margins and operating expenses, lack of market acceptance or demand for new product lines, price competition, conditions in the contamination control industry and the economy in general, as well as legal proceedings. The economic risk associated with material cost fluctuations and inventory obsolescence is significant to the Company. The ability to manage inventories through procurement and utilization of component materials and the ability to generate new glove sales could have a significant impact on future results of operations or financial condition. Historical results are not necessarily indicative of the operating results for any future period.

Subsequent written and oral forward looking statements attributable to the Company or persons acting on the Company’s behalf are expressly qualified in their entirety by cautionary statements in this Form 10-QSB and in other reports that have been filed with the Securities and Exchange Commission. The following discussion should be read in conjunction with the Consolidated Financial Statements and the Notes thereto included elsewhere in this filing.

Overview

The Company has incurred substantial losses since its inception in 1990, and has relied on working capital provided by Trilon Dominion (previously Dominion Capital, Inc.) in the form of both debt and equity to fund its operations. Management believes that Trilon Dominion will continue to support the Company’s working capital needs as necessary through the end of fiscal year 2002.

Accordingly, the accompanying condensed consolidated financial statements have been prepared assuming the Company will continue to operate as a going concern. Should Trilon Dominion discontinue providing working capital support to the Company, the Company would have insufficient working capital to meet its operational needs for the foreseeable future.

In May of fiscal year 2000, the Company sold certain assets and selected liabilities of the Company’s Wilshire Contamination Control division (the “Division”) to Foamex Asia Co. Ltd. (the “Buyer”), an affiliate of Foamex International (FMX:NASDAQ) for a potential sales price of $2,500,000 or more. The sale was finalized on May 19, 2000. Substantially all of the historic revenues reported by the Company related to this division.

As no proceeds were due to the Company on the date of closing, the Company recorded a receivable in the amount of $945,000, which equated to the net book value of the net assets sold. All payments of the sales price were applied against the receivable, under the cost recovery method, with no recognition of gain until the receivable was paid in full. On November 29, 2001, the Company received a payment of $258,000 from Foamex Asia Co. Ltd., in compliance with the terms of the Agreement, which was applied against the receivable. During the first nine months of 2002, the Company received three additional payments totaling approximately $780,000 from Foamex Asia Co. Ltd., of which $687,000 was applied to the remaining principal balance — now paid in full — and $93,000 recognized as other income in the third quarter ended August 31, 2002.

In addition to the sale of assets, the Buyer and Seller entered into an agreement (the “Ongoing Service Agreement”) where the Company agreed to provide Foamex, for due consideration, certain labor, facilities, services, personnel and other items with respect to Foamex’s ongoing operation of the Division’s business. The agreement commenced on May 19, 2000, and has been subsequently amended to continue until December 31, 2002. The Company anticipates receiving approximately $550,000 from the agreement during fiscal year 2002, of which $345,000 has been received through August 31, 2002.

Effective September 18, 2000, the Company signed a Product Development, Purchase and License Agreement (the “Agreement”) with the LYCRA® division of E. I. DuPont de Nemours and Company (“DuPont”). Under the Agreement, DuPont developed and began to supply a new proprietary polyurethane material (the “Material”) used by Wilshire to manufacture and sell a disposable polyurethane glove for industrial and non-industrial cleanroom applications.

Company can obtain annual non-exclusive rights in these markets upon achievement of lesser annual thresholds of $3.45M, $8.15M and $13.25M for the 12-month periods ending June 30, 2003, 2004 and 2005, respectively. Given that Company’s sales for the first nine months of fiscal 2002 totaled $384,000, it is unlikely that the Company will meet the minimum revenue requirements for the 12 month period ending June 30, 2003. Although the Company is in discussions with DuPont regarding the modification of the revenue threshold requirements, the License Agreement has not been modified nor are there any assurances from DuPont that it will be. Therefore, there can be no assurance that the DuPont will extend the rights to use DuPont’s Material, on an exclusive or non-exclusive basis, for periods beyond the initial two-year period.

During fiscal year 2001, the Company finalized a commercial version of DuraCLEAN® with Lycra® glove. The Company began a controlled production ramp up as it focused on process and yield improvement programs.

The process and yield improvement programs were completed in the last half of fiscal year 2001, along with the completion of extensive tests for cleanliness, durability, strength and comfort.

The Company initially targeted its glove sales to the Japanese semiconductor and diskdrive industries and introduced the glove for evaluations at key customer sites. In the second half of 2001, the Company introduced the new glove into the US Medical Device market.

In October 2001, the Company finished a retrofit of its glove dipping line to maximize production capacity for the new glove. As part of the retrofit program, the Company made a strategic decision to design new glove formers in order to improve the fit of the glove and thus improve product yields. Vendor design changes pushed the delivery of the formers to the third and fourth quarter of fiscal year 2002. Consequently, during the nine months of fiscal 2002, the Company experienced lower production levels than planned as it continued to produce gloves on the old glove formers.

In the third quarter of fiscal 2002, productions levels and yields increased as the Company began to replace old glove formers with the newly designed formers and completed mechanical improvements to the glove dipping process. These enhancements to the production process contributed to improvements to product quality and consistency during the quarter. The Company subsequently made a marketing decision to retrieve unsold inventory of product (made early in the quarter) from its Japanese distributor and provide newer, more consistent product. Accordingly, a reserve for potential sales returns totaling $52,000 was recorded at August 31, 2002.

During the third quarter, the Company obtained FDA clearance to sell the Company’s DuraCLEAN® with Lycra® glove into the medical examination glove markets. The FDA clearance positioned the Company to expand its target customers in the medical device, pharmaceutical and biotechnology industries. In anticipation of the FDA approval, the Company completed certain plant improvements during the third quarter to allow it to service customers from

these markets.

The Company has adopted the provisions of SFAS 121, “Accounting for the Impairment of Long-Lived Assets and for Long-Lived Assets to be Disposed Of”. This statement requires that long-lived assets and certain identifiable intangibles be reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by comparison of the carrying amount of an asset to future net cash flows expected to be generated by the asset. If such assets are considered impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the fair value of the assets. Assets to be disposed of are reported at the lower of the carrying amount or fair value less costs to sell.

The Company has evaluated the recoverability of the assets associated with its existing glove plant by measuring the carrying cost of those assets – after write downs — against the estimated undiscounted future cash flows associated with those assets. The future cash flows calculated by the analysis appeared sufficient to recover the value of the assets and thus no write down of the asset was recorded.

As previously discussed, during the third quarter of fiscal 2002, the Company continued extensive capital expansion programs to increase capacity levels and production efficiencies of the glove plant. The Company entered into a contract with a glove line manufacturer to construct two additional glove lines, with installation of the first of the two lines to take place in the last fiscal quarter of 2002. Due to the length of time needed to expand manufacturing capacity, (9 to 12 months per glove line), the Company anticipates that full capacity and manufacturing efficiencies associated with the new lines will not be attained until mid 2003.

The Company’s sales of $384,000 for the first nine months of fiscal 2002 were primarily to key Japanese semiconductor and diskdrive customers. In addition to serving its Japanese customers, the Company focused on expanding the introduction of the glove to domestic markets, with particular focus in the personal protection and medical device markets. The Company began receiving orders in the third quarter of fiscal 2002 from customers within these markets.

The sale of the Company’s Wilshire Contamination Control Division along with the extensive development cycle of the new glove has continued to impact the Company’s ability to generate cash. The Company further anticipates that additional funding of working capital totaling approximately $3 Million through calendar year 2002, will be required as the Company focuses on ramping up production capacity and sales of its new polyurethane glove.

As of November 30, 2001, the Company had used its current credit facilities. Consequently, in order to raise funds to support its working capital needs for fiscal 2002, the Company signed a Stock Option Agreement (“Agreement”) with Trilon Dominion Partners, L.L.C. (“Trilon”).

Under the Trilon Agreement, on December 17, 2001 the Company issued to Trilon (the Company’s largest shareholder owning over 83% of the Company’s outstanding shares), 8,011,038 shares of the Company’s unissued authorized stock in cancellation of $1,291,000 of indebtedness and interest. The Agreement also granted to Trilon the following three options: (i) an option, issued on December 17, 2001, to purchase 16,445,900 shares of Common Stock at $0.14 per share, exercisable at any time before 2003; (ii) an option, to be issued upon approval of an increase in the Company’s authorized stock, to purchase an additional 1,600,000 shares of Common Stock, which may also be purchased at $0.14 per share at any time before 2003; and (iii) an additional option to purchase from the Company at $0.14 per share that number of shares of Common Stock necessary to increase Trilon’s beneficial ownership of the Company’s Common Stock to 90% of the shares outstanding after exercise of all options granted in the Agreement and after the deemed exercise of all other then outstanding options and warrants. The options granted to Trilon under the Agreement may be exercised for cash or, at Trilon’s election, by canceling outstanding indebtedness of the Company to Trilon in an amount equal to the exercise price. An Amendment to the Articles of Incorporation to increase the Company’s authorized number of shares of common stock by 50,000,000 to 100,000,000 was approved by the Company’s shareholders at its Annual Meeting of Shareholders on May 13, 2002 and became effective on May 17, 2002.

Trilon Dominion has advised the Company that it will continue to support the Company as necessary through the end of calendar year 2002; however, as no written agreement exists, no assurance of their support can be given. (See discussion on Going Concern in Note 2 of the Notes to the Consolidated Financial Statements).

Results of Operations

Net Sales

The Company markets its products directly to end-users through a limited number of internal sales personnel as well as through international, national and regional distributors. Revenue for all sales is recognized when title transfers, generally when products are shipped.

Net sales increased by $132,000 (528%) to $157,000 in the third quarter of 2002 as compared to sales of $25,000 for the comparable period in 2001. Net sales increased by $229,000 (148%) to $384,000 for the first nine months of 2002 as compared to $155,000 for the first nine months of 2001.

The gross sales for the quarter and the first nine months of fiscal 2002 were reduced by a sales return allowance totaling $52,000. The Company experienced quality issues with production of certain glove sizes during the first two months of the third quarter. Enhancements to the production process in August 2002 addressed the problem. The Company subsequently made a marketing decision to retrieve unsold inventory of product made during this time period from its Japanese distributor and recorded a reserve for potential sales returns at August 31, 2002.

The increase in net sales for quarter and first nine months, is due to an increase in orders for the Company’s DuraCLEAN® with Lycra® glove from key Japanese semiconductor and diskdrive customers.

Gross Margin

For the third quarter ended August 31, 2002, the Company recorded a negative gross margin of $1,574,000 as compared to a negative gross margin of $799,000 in the same period of 2001. For the first nine months of 2002, the Company recorded a negative gross margin of $3,684,000 as compared to a negative gross margin of $1,836,000 for the comparable period in 2001. The losses for the quarter and first nine months were primarily attributable to high-unabsorbed operating costs of its glove manufacturing plant as the Company ramped up production in 2002 of its new polyurethane glove made with proprietary material supplied by Dupont and began extensive capital expansion projects.

Marketing and Selling Expenses

Marketing and selling expenses increased by $82,000 (38%) to $296,000 for the quarter ended August 31, 2002 from $214,000 for the comparable period of 2001. The first nine months of Marketing and selling expenses increased by $253,000 (50%) to $757,000 from $504,000 for the first nine months of 2001. The increase in expenses for the quarter and first nine months, as compared to 2001, was primarily attributable to an increase in headcount as well as an increase in marketing, tradeshow and travel expenses associated with the introduction of the new glove to customers.

General and Administrative Expenses

General and administrative expenses include costs related to the Company’s administrative costs such as executive and office salaries, related payroll expenses, investor relations, professional fees, supplies and utilities.

General and administrative expenses decreased by $71,000 (23%) to $244,000 for the third quarter of 2002 from $315,000 in the third quarter of 2001. For the first nine months of fiscal 2002, General and Administrative expenses increased by $31,000 (3%) to $1,247,000 from $1,216,000 for the first nine months of fiscal 2001. The decrease in the quarter was primarily due to a reversal of a year to date accrual of a Company bonus plan for 2002. The increase in the first nine months was primarily due to increases in headcount.

Research and Development

No research and development expenses were incurred for the third quarter of fiscal 2002 as compared to $10,000 for the comparable period in 2001. Research and development expenses decreased by $32,000 (94%) to $2,000 as compared to Research and development expenses of $34,000 for the first nine months of 2001. The decrease in expenses for the quarter and first nine months was primarily due to the commercialization of the Company’s DuraCLEAN® with Lycra® glove during the last half of fiscal year 2001.

Loss Due to Impairment of Fixed Assets

During the third quarter of fiscal 2002, the Company continued extensive capital expansion programs to increase capacity levels and production efficiencies of the glove plant. As part of the expansion program, the Company identified certain assets totaling $600,000 associated with the original glove dipping line to be replaced early in fiscal 2003. In accordance with the Company’s accounting policies, the depreciable life of the asset would be adjusted to fully depreciate the asset by early 2003. However, due to the uncertainty as to the Company’s ability to recover its investment in its long-term assets through the generation of future net cash flows through 2003, the Company recognized a loss due to impairment of such assets totaling $600,000 in the third quarter ended August 31, 2002.

Other Income/Expense

Other income/expense of $137,000 increased by $56,000 (69%) for the quarter ended August 31, 2002 as compared to $81,000 of Other income/expense for the comparable period in 2001. Other income/expense of $137,000 for the quarter ended August 31, 2002 was comprised of approximately $ 292,000 of Other income offset by approximately $156,000 of Other expense. Other income consisted primarily of $117,000 of consulting income from Foamex Asia Co. Ltd., $50,000 from Dupont for marketing support (as agreed to in the September 2000 Product Development, Purchase and License Agreement between the Company and DuPont), $93,000 from Foamex Asia Co. Ltd. (in accordance with the terms of the sale of the Wilshire Contamination Control Division to Foamex Asia in May 2000 -see Note 5) and $33,000 in forgiven trade payables. Other expenses for the quarter consisted primarily of $97,000 from a write off of assets, $18,000 for payment of a life insurance premium for Mr. Steve Scibelli, a former President and CEO of the Company (as dictated by Mr. Scibelli’s Employment Agreement) and $32,000 in royalty payments to Dupont.

Other income/expense of $262,000 for the first nine months of 2002 decreased by $18,000 (6%) as compared to Other income/expense of $280,000 for the first nine months of 2001. The decrease in Other income/expense for the first nine months is due to the items noted above as well as the payment of $44,000 for the purchase of a new automobile for Mr. Steve Scibelli, as dictated by Mr. Scibelli’s Employment Agreement.

Interest Expense, Net

Interest expense increased by $103,000 (22%) to $578,000 for the third quarter of fiscal year 2002 as compared to $475,000 of Interest expense for the comparable period in 2001. Interest expense of $1,928,000 for the first nine months of 2002 increased by $544,000 (39%) from Interest expense of $1,384,000 for the first nine months of 2001. The increase in Interest expense for the quarter is due to an increase in debt outstanding mitigated by a decrease in prime rate. The increase in Interest expense for the first nine months is primarily due to a charge of $375,000 in the first quarter of 2002 related to the fair value of a stock option agreement entered into with Trilon on December 17, 2001 as well as an increase in debt outstanding. Interest expense related primarily to the line of credit due to Trilon Dominion Partners, LLC. (See Note 6).

Income Taxes

For the quarters ended August 31, 2002, and August 31, 2001, the Company sustained losses for both financial reporting and income tax purposes. A tax provision of $1,000 related to state income taxes was recorded in the condensed financial statements for 2001 and 2002.

Going Concern

The Company anticipates continuing substantial negative cash flow from operating and investing activities through the next twelve months. The Company has projected its cash flow needs to be approximately $3 million for the remainder of calendar 2002. Trilon Dominion, the Company’s largest shareholder with over 83% of the shares outstanding, has acknowledged the Company’s cash flow needs and has indicated its commitment to provide financial support to the Company through the end of the calendar year 2002 to the extent of such budgeted cash flow requirements. However given that no written commitment exists, the Company is exposed to the substantial risk that it will not receive the funds from Trilon Dominion to fund present and future working capital needs. In the event that such funds are not received it is unlikely that the Company will be successful in raising capital from other sources. If adequate funds are not available to finance current operations, the Company will be unable to execute its business development efforts and may be unable to continue as a going concern.

1) During fiscal 2000, the Company sold selected assets and liabilities totaling $945,000 related to the Company’s Wilshire Contamination Control to Foamex Asia Co. LTD. (the “Buyer”), an affiliate of Foamex International (FMX: NASDAQ) for a potential sales price up to $2,500,000 (See Note 5). Payments of the sale price are due from the Buyer on a quarterly basis based on a fixed percentage of sales by the Buyer of certain products. Foamex International is an international developer, manufacturer and supplier of high-quality foam, including key materials utilized in contamination control environments. Foamex Asia Co. Ltd., located in Singapore and in Thailand, is currently a major supplier of specialty foam products to the Asian market.

In accordance with the terms of the sale agreement, a payment in the amount of $258,000 was received from Foamex Asia Co. Ltd., on November 29, 2001 and applied against the receivable. During the first nine months of 2002, the Company received three additional payments totaling approximately $780,000 from Foamex Asia Co. Ltd., of which $687,000 was applied to the remaining principal balance-now paid in full- and $93,000 recognized as other income in the third quarter ended August 31, 2002.

The Company believes that with the potential of a return of $2,500,000 -of which $1,038,000 has been received by the Company as of August 31, 2002- on the sale of its contamination control division to Foamex Asia Co., Ltd., with the cost-sharing agreements in place to lower operating costs, with the sales of its new glove, and with continued funding from Trilon Dominion, the Company will position itself to begin generating sufficient cash flow to fund working capital and investment activities by the end of 2003. If the Company does attain its sales goals, it believes that it will be able to raise additional capital, as needed in the future. There can be no assurances, however, that the Company will be successful in any of the above mentioned actions or plans on a timely basis, or at all.

Liquidity and Capital Resources

Management assesses the Company’s liquidity by its ability to generate cash to fund its operations. Significant factors in the management of liquidity are: funds generated by operations; levels of accounts receivable, inventories, accounts payable and capital expenditures; adequate lines of credit; and financial flexibility to attract long-term capital on satisfactory terms.

During 2001 and for the first nine months of 2002, the Company has not generated sufficient cash from operations to fund its working capital and equipment purchase requirements. Net cash used in operating activities was $4,614,000 for the first nine months of 2002 versus net cash used in operating activities of $2,773,000 for the corresponding period in 2001. The increase in the cash used in operating activities was primarily due to the expansion of the Company’s glove factory during the first nine months of fiscal 2002.

Net cash used in investing activities was $3,478,000 for the first nine months of 2002, versus net cash used in investing activities of $280,000 for the first nine months of 2001. The higher investing activities for fiscal 2002 were related to capital expansion projects to the Company’s glove factory, offset by proceeds received in connection with the sale of assets to Foamex.

Net cash provided by financing activities was $8,344,000 for the first nine months of fiscal 2002 versus $3,165,000, for 2001, respectively. The financing in both years was obtained from Trilon Dominion Partners, LLC.

On March 31, 1998, the Company and Trilon Dominion completed an Amended and Restated Credit Agreement and Revolving Line of Credit (the “Amended Agreement”) secured by the Company’s assets.

In fiscal 2000, the Company issued demand notes totaling $2,813,000 under the line of credit agreement. The notes issued in fiscal 2000 bear interest at a rate of prime plus 3% (13.0% at November 30, 2000).

On December 17, 2001, the Company signed a Stock Option Agreement with Trilon. Under the Trilon agreement, the Company issued to Trilon 8,011,038 shares of the Company’s unissued authorized stock in cancellation of three demand notes plus respective interest which totaled $1,291,000. The fair value of the option granted was estimated to be $375,000, which was recorded as a charge to earnings in the first quarter of 2002.

As of September 1, 2002, the Company has used its current credit facilities and anticipates continuing negative cash flow from operating and investing activities through calendar 2002. The Company has projected its cash flow needs to be approximately $3 Million for the remainder of calendar 2002. Trilon Dominion, the Company’s largest shareholder with over 83% of the shares outstanding, has acknowledged the Company’s cash flow needs and has indicated its commitment to provide financial support to the Company through calendar year 2002 to the extent of such budgeted cash flow requirements. However, given that no written commitment exists, the Company is exposed to the substantial risk that it will not receive the funds from Trilon Dominion to fund present and future working capital needs. If such commitment is not met, it is likely that the Company will not have the necessary resources to fund its operations for the next 12 months.

Risk Factors

On September 30, 2002, the Pacific Maritime Association (PMA), which represents port employers on the West Coast, extended its lockout of dockworkers at all West Coast ports because of an ongoing dispute with the International Longshore and Warehouse Union (ILWU). The Company’s final delivery of its redesigned formers has been delayed due to the strike. If the strike continues into the fourth quarter of fiscal 2002, planned increases in production for that quarter may be impacted.

The Company’s business depends on the free flow of products and services through the channels of commerce. Recently, in response to terrorists’ activities and threats aimed at the United States, transportation, mail, financial and other services have been slowed or stopped altogether. Further delays or stoppages in transportation, mail, financial or other services could have a material adverse effect on the Company’s business, results of operations and financial condition. Furthermore, the Company may experience an increase in operating costs, such as costs for transportation, insurance and security as a result of the activities and potential activities. The Company may also experience delays

in receiving payments from payers that have been affected by the terrorist activities and potential activities. The U.S. economy, in general, is being adversely affected by the terrorist activities and potential activities and any economic downturn could adversely impact the Company’s results of operations, impair its ability to raise capital or otherwise adversely affect its ability to grow the business.

Recent Accounting Pronouncements

In July 2001, the Financial Accounting Standards Board (FASB) issued Statement of Financial Accounting Standards No. 141 (SFAS 141), Business Combinations, which eliminates the pooling method of accounting for intangible assets and goodwill acquired in a business combination initiated after June 30, 2001. In addition, SFAS 141 addresses the accounting for intangible assets and goodwill acquired in a business combination. This portion of SFAS 141 is effective for business combinations completed after June 30, 2001. The Company does not expect SFAS 141 will have material impact on its financial position or results of operations.

In July 2001, The FASB issued Statement of Financial Accounting Standards No. 142 (SFAS 142), Goodwill and Intangible Assets, which revises the accounting for purchased goodwill and intangible assets. Under SFAS 142, goodwill and intangible assets with indefinite lives will no longer be amortized and will be tested for impairment at least annually. SFAS 142 is effective for fiscal years beginning after December 15, 2001, with earlier adoption permitted. The Company does not expect SFAS 142 will have a material impact on the Company’s financial position or results of operations.

In August 2001, FASB issued SFAS No. 144, Impairment or Disposal of Long-Lived Assets, which addresses accounting and financial reporting for the impairment or disposal of long-lived assets. This standard is effective for the Company’s fiscal year beginning December 1, 2002. The Company is currently evaluating the impact, if any, the implementation of this Statement will have on the Company’s financial position or results of operations.

Item 3. Procedures and Controls

Within the 90 days prior to the date of this report, the Company carried out an evaluation, under the supervision and with the participation of the Company’s management, including the Company’s Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of the Company’s disclosure controls and procedures pursuant to Exchange Act Rule 13a- 14. Based upon that evaluation, the Chief Executive Officer and Chief Financial Officer concluded that the Company’s disclosure controls and procedures are effective. There were no significant changes in the Company’s internal controls or in other factors that could significantly affect these controls subsequent to the date of their evaluation

PART II — OTHER INFORMATION

Item 1. Legal Proceedings:


	For information regarding legal proceedings, refer to the information contained in the Company’s annual report on Form 10-KSB for the fiscal year ended November 30, 2001 under the heading, “Legal Proceedings” and Note 7 to the financial statements therein.

Item 2. Changes in Securities and Use of Proceeds:


	None since May 17, 2002 when the Articles of Incorporation were amended to increase the authorized number of shares from 50,000,000 to 100,000,000.

Item 3. Defaults Upon Senior Securities:

None.

Item 4. Submission of Matters to a Vote of Security Holders:

None.

Item 5. Other Information:

None.

Item 6. Exhibits and Reports on Form 8-K

(a) Exhibits:


10.221		Demand note dated June 7, 2002 between the Registrant and Trilon Dominion Partners, L.L.C.

10.222		Demand note dated July 2, 2002 between the Registrant and Trilon Dominion Partners, L.L.C.

10.223		Demand note dated August 6, 2002 between the Registrant and Trilon Dominion Partners, L.L.C.

10.224		Demand note dated August 19, 2002 between the Registrant and Trilon Dominion Partners, L.L.C.

99.1		Certifications of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to section 906 of the Sarbanes-Oxley Act of 2002.

(b) Reports on Form 8-K:

None.

SIGNATURES

In accordance with requirements of the Securities Exchange Act, the registrant has caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.


	WILSHIRE TECHNOLOGIES, INC


Dated: October 14,2002	By:	/S/ Kathleen E. Terry

		Kathleen E. Terry Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer)

I, Kevin Mulvihill, certify that:

	1.		I have reviewed this quarterly report on Form 10-Q SB of Wilshire Technologies, Inc.

	2.		Based on my knowledge, this quarterly report does not contain any untrue statement of material fact or omit to state a material fact necessary to make the statements made. In light of the circumstances under which such statements were made, not misleading with respect to the period covered by this quarterly report.

	3.		Based on my knowledge, the financial statements, and other financial information, included in this quarterly report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this quarterly report.

	4.		The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act rules 13a-14 and 15d-14) for the registrant we have:


		a		designed such disclosure controls and procedures to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this quarterly report is being prepared;

		b		evaluated the effectiveness of the registrant’s disclosure controls and procedures as of a date within the 90 days prior to the filing date of this quarterly report, (the “Evaluation Date”); and

		c		presented in this quarterly report our conclusions about the effectiveness of the disclosure controls and procedures based on our evaluation as of the Evaluation Date;

The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent function):


		a		all significant deficiencies in the design or operation of internal controls which could adversely affect the registrant’s ability to record, process, summarize and report financial data and have identified for the registrant’s auditors any material weaknesses in internal controls; and

		b		any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal controls; and

The registrant’s other certifying officer and I have indicated in this quarterly report whether or not there were significant changes in internal controls or in other factors that could significantly affect internal controls subsequent to the date of our most recent evaluation, including any corrective actions with regard to significant deficiencies and material weaknesses.


Date: October 14, 2002				/S/ Kevin T. Mulvihill

				Kevin T. Mulvihill, Chief Executive Officer

I, Kathleen Terry, certify that:

	1.		I have reviewed this quarterly report on Form 10-Q SB of Wilshire Technologies, Inc.

	2.		Based on my knowledge, this quarterly report does not contain any untrue statement of material fact or omit to state a material fact necessary to make the statements made. In light of the circumstances under which such statements were made, not misleading with respect to the period covered by this quarterly report.

	3.		Based on my knowledge, the financial statements, and other financial information, included in this quarterly report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this quarterly report.

	4.		The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act rules 13a-14 and 15d-14) for the registrant we have:


		a		designed such disclosure controls and procedures to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this quarterly report is being prepared;

		b		evaluated the effectiveness of the registrant’s disclosure controls and procedures as of a date within the 90 days prior to the filing date of this quarterly report, (the “Evaluation Date”); and

		c		presented in this quarterly report our conclusions about the effectiveness of the disclosure controls and procedures based on our evaluation as of the Evaluation Date;


		a		all significant deficiencies in the design or operation of internal controls which could adversely affect the registrant’s ability to record, process, summarize and report financial data and have identified for the registrant’s auditors any material weaknesses in internal controls; and

		b		any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal controls; and


Date: October 14, 2002		/s/ Kathleen E. Terry

		Kathleen E. Terry, Chief Financial Officer

Wilshire Inactive 10QSB2002 Q3 Quarterly report (small business)

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents